Have a personal or library account? Click to login

Levosimendan protects against ischemia – reperfusion injury in the human heart muscle. A pilot study

Open Access
|Feb 2023

Authors

Marcin Kunecki

ORCID

mkunecki@op.pl

Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland

Tomasz Oleksy

ORCID
Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland

Jerzy Nozynski

ORCID
Department of Histology and Embryology, Medical University of Silesia, Katowice, Poland

Piotr Podolec

ORCID
Department of Cardiac and Vascular Diseases, John Paul II Hospital, Jagiellonian University Medical College, Kraków, Poland

Jolanta Biernat

ORCID
Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland

Marek Andrzej Deja

ORCID
Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland

Krzysztof Stanislaw Golba

ORCID
Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland

Wojciech Plazak

ORCID
Department of Cardiac and Vascular Diseases John Paul II Hospital, Jagiellonian University Medical College, Kraków, Poland
DOI: https://doi.org/10.2478/cipms-2022-0038 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 219 - 223
Submitted on: Aug 30, 2022
Accepted on: Dec 11, 2022
Published on: Feb 9, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2023 Marcin Kunecki, Tomasz Oleksy, Jerzy Nozynski, Piotr Podolec, Jolanta Biernat, Marek Andrzej Deja, Krzysztof Stanislaw Golba, Wojciech Plazak, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.